CURRENT ACADEMIC ROLE & RESPONSIBILITIES

Professor

沙巴体育 on biotherapeutics discovery and development.

Teaching Role for MSc on basics of biotherapeutics.

Profile:?

Google Scholar profile:?

https://scholar.google.co.in/citations?hl=en&user=HUHX8DsAAAAJ

LinkedIn profile:

https://www.linkedin.com/in/sreesh/

.

Experience

Institution / Organisation	Designation	Role	Tenure
沙巴体育 Centre for Biotherapeutics 沙巴体育, 沙巴体育 Academy of Higher Education	Professor	沙巴体育 faculty, teaching, grant writing, industry partnership	September 2023 to date
Oblique Therapeutics AB, Gothenburg, Sweden	Chief Development Officer	Responsible for preclinical development and translational research across all programs. Program lead for three oncology programs two of which met preclinical proof-of-concept and transitioned into further development	June 2019 - May 2023
Novel Therapeutics - Biocon Ltd., Bangalore, India	Vice President and Head	Responsible for novel therapeutic portfolio of two clinical, two advanced preclinical and several discovery programs. Led a bi-functional mAb from early discovery to IND; currently in Phase 1/2 in the US	Jan 2015 - May 2019
Oncology Translational Discovery Unit, Piramal Enterprises Ltd., Mumbai, India	Vice President and Head	Responsible for a portfolio of oncology discovery programs. Contribution to development portfolio on translational research aspects.	Feb 2013 – Dec 2014
Cancer Biology and Translational Science, Jubilant Biosys, Bangalore, India	Director and Head	Responsible for delivery of research milestones in client projects; key point of contact for two large US Pharma companies. Contribution to Phase 1 clinical development of an in-licensed program.	Sept 2010 – Jan 2013
Translational Medicine – Oncology, Pfizer Inc., San Diego, CA, USA	Associate Director	Responsible for translational medicine, biomarker, and companion diagnostic strategies in multiple clinical development programs. Member of core clinical project teams contributing to clinical trial protocols, investigator meetings. Member of core discovery teams contributing to preclinical and translational aspects.	April 2006 – Aug 2010
Preclinical Biology, CGI Pharma Inc. (later Gilead Sciences Inc.), Branford, CT, USA	Principal Scientist	Contributed to Lead identification, optimization, candidate selection and preclinical development of drug candidates	Jan 2001 – March 2006
Discovery Oncology, Pfizer Inc., St. Louis, MO	Post-Doctoral Fellow	Responsible for understanding the mechanisms of action of drug candidates	May 1998 – Dec 2000